Fludeoxyglucose F-18 Injection, Solution
Product Images NDC 40098-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 40098-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trustees Of The University Of Pennsylvania, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Flu0g 0004 01)

FDA Label Image

Label On Product Vial (Flu0g 0008 02)

Label On Product Vial (Flu0g 0008 02)
Fludeoxyglucose F18 Inj., is a radioactive material used for diagnostic purposes. It contains 0.74 - 7.40 GBq/mL (20 - 200mCi/mL) and must be stored upright in a shielded container at 20° to 25°C (68" to 77°F). The expiration time is 12 hours after EOS time. The correct dosage must be calculated from the date and time of calibration. Half-life of this injection is 109.7 minutes. The product is manufactured by Cyclotron Facility and must be aseptically withdrawn and handled by caution as it is a radioactive material. The University of Pennsylvania situated in Philadelphia, PA 19104 has used this radioactive material for their diagnostic purposes and warns not to use it if cloudy or contains particulate matter.*
FDA Label Image

Label On Lead Shield Container (Flu0g 0008 03)

Label On Lead Shield Container (Flu0g 0008 03)
This is a description of Fludeoxyglucose F18 Injection, USP, a radioactive diagnostic drug that is administered intravenously. It comes in a 25 mL multiple-dose vial and has a concentration of 20 to 200 mCi/mL. The medication does not contain any preservatives, and it must be calculated for the correct dosage from the date and time of calibration because it has a half-life of 109.7 minutes. It is important to store it in a shielded container between 20° to 25°C and to not use it if it is cloudy or contains particulate matter. The drug expires 12 hours after End of Synthesis (EOS), which is indicated on the vial. It is manufactured by the Cyclotron Facility at the University of Pennsylvania, Philadelphia.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.